Raltegravir in second-line ART in resource-limited settings
Lancet HIV
.
2016 Jun;3(6):e240-1.
doi: 10.1016/S2352-3018(16)30014-5.
Epub 2016 Apr 18.
Authors
Andreas D Haas
1
,
Olivia Keiser
2
Affiliations
1
Institute of Social and Preventive Medicine, University of Bern, Bern CH-3012, Switzerland.
2
Institute of Social and Preventive Medicine, University of Bern, Bern CH-3012, Switzerland. Electronic address: olivia.keiser@ispm.unibe.ch.
PMID:
27240783
DOI:
10.1016/S2352-3018(16)30014-5
No abstract available
Publication types
Comment
MeSH terms
Anti-HIV Agents
CD4 Lymphocyte Count
HIV Infections*
Humans
Raltegravir Potassium*
Viral Load
Substances
Anti-HIV Agents
Raltegravir Potassium